New

Fox Chase Cancer Center

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

Fox Chase Cancer Center provides cancer research, treatment, and prevention.

HQ Location

Philadelphia (United States)

Founded

1904

Employees

1001 - 5000

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

At Fox Chase Cancer Center, defeating cancer is our calling.



Fox Chase is one of the nation’s first dedicated cancer hospitals, and our researchers and physicians have made major contributions to scientific advancement since our establishment more than a century ago in 1904.



Fox Chase scientists have made breakthroughs in cancer prevention, diagnosis, treatment, and survivorship, and have earned the highest awards in their fields, including two Nobel Prizes. We translate these pioneering discoveries into world-class clinical care every day - with a single purpose: to defeat cancer and help the people it impacts.



This calling is rooted in our cancer-specific, multidisciplinary teams of doctors, researchers, practitioners, and five-time Magnet designated nurses, who are all more than specialists in cancer; they are international experts in distinct types of cancer, whose deep and focused expertise provides the best chance for the best outcome anywhere along the cancer continuum.



And they’re helping to advance the way cancer treatment is delivered around the world. The way we work together, with this single, shared passion for our patients’ well-being, is what makes us truly unique.



For more information, visit our website at FoxChase.org or call 888-FOX-CHASE (888-369-2427.)